Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 32,811 | 21,303 | 7,632 | 27,376 | 23,529 |
| Gross Profit | 32,811 | 21,303 | 7,632 | 27,376 | 23,529 |
| Operating Expenses | 61,043 | 45,357 | 57,752 | 43,322 | 45,769 |
| Operating Income | -28,232 | -24,054 | -50,120 | -15,946 | -22,240 |
| Other Income | 1,414 | 3,322 | 1,689 | 2,335 | 2,404 |
| Pre-tax Income | -26,818 | -20,732 | -48,431 | -13,611 | -19,836 |
| Net Income Continuous | -26,818 | -20,732 | -48,433 | -13,611 | -19,836 |
| Net Income | $-26,818 | $-20,732 | $-48,433 | $-13,611 | $-19,836 |
| EPS Basic Total Ops | -0.26 | -0.20 | -0.48 | -0.13 | -0.20 |
| EPS Basic Continuous Ops | -0.26 | -0.20 | -0.48 | -0.13 | -0.20 |
| EPS Diluted Total Ops | -0.26 | -0.20 | -0.48 | -0.13 | -0.20 |
| EPS Diluted Continuous Ops | -0.26 | -0.20 | -0.48 | -0.13 | -0.20 |
| EBITDA(a) | $-25,819 | $-22,508 | $-48,474 | $-14,176 | $-20,626 |